Personalized Onco-Genomics sets a global precedent
November 2, 2014
The Personalized Onco-Genomics (POG) Program sets a global precedent both in terms of the diversity of cancers investigated and the number of patients participating. The 2014 Inspiration Gala raised $5 million to support part II of POG, seeing more than 300 patients enter a world-first clinical study that provides oncologists with gamechanging genomic data to guide treatment decisions. POG is a one-of-a-kind program to investigate the feasibility of a truly personalized strategy for cancer therapy and seeks to: decode the genomic structure of each patient’s cancer. Read More.